GlassScriptPhysician profile
Steven Kim
NPI 1124135348
$9,909.47
in general payments reported to CMS, 2019-2025
17 companies · $6,008 in 2025
The $6,008 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2022: $480 · 2023: $533 · 2024: $2,592 · 2025: $6,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $2,577 · Food and Beverage: $1,757 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $2,576.86 |
| Food and Beverage | $1,756.79 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,737.45 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $1,245.66 | 2022-2024 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Solventum Corporation | $1,082.36 | 2024-2025 | 3m Ioban, Ioban 2, Prevena |
| Ethicon US, LLC | $433.47 | 2022-2025 | Harmonic, Echelon; Endopath, Vistaseal |
| Aroa Biosurgery Incorporated | $369.08 | 2023-2025 | |
| Kci USA, INC. | $280.17 | 2019-2023 | Abthera Advance |
| Acell, INC. | $123.88 | 2019 | |
| Kerecis Limited | $118.22 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kls-Martin L.P. | $117.19 | 2024 | |
| Heron Therapeutics, INC. | $110.00 | 2022 | |
| Baxter Healthcare | $89.88 | 2019 | |
| Zimmer Biomet Holdings, INC. | $74.53 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $48.36 | 2023-2024 | Inpefa |
| Abbvie INC. | $34.07 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $17.98 | 2024 | Arcalyst |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.